Don’t let the cost of psoriasis treatment steal your quality of life. We help eligible patients
access Duobrii (halobetasol/tazarotene lotion) for as little as $69.95 per month through
manufacturer Patient Assistance Programs.
The Duobrii Prescription Assistance Program is a manufacturer-sponsored initiative designed to help qualifying patients who cannot afford Duobrii access the medication at no or reduced cost. The program is available to U.S. citizens and legal residents, including commercially insured patients whose insurance does not cover the medication. A copay savings card is also available at participating pharmacies.
Plaque psoriasis covers your skin with thick, red, scaly patches that crack, itch, and sometimes bleed — patches that are visible to everyone and affect every aspect of your daily life. When your dermatologist prescribes Duobrii because you need the combined power of a steroid and retinoid in a single daily application, discovering that one tube costs over $1,000 can feel like your disease is being compounded by the healthcare system itself. AffordMyPrescriptions ensures that breakthrough topical psoriasis treatment is accessible regardless of your financial situation. For a flat $69.95 per month, our Patient Advocates manage every step of your enrollment — preparing the application, coordinating with your dermatologist, tracking approval, and handling refills and re-enrollment so your psoriasis treatment is never interrupted.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,020.00 | Save ~$229/mo |
| CVS Pharmacy | ~$1,015.00 | Save ~$229/mo |
| Walmart | ~$1,005.00 | Save ~$229/mo |
| Costco | ~$1,001.00 | Save ~$240/mo |
| Kroger | ~$1,003.00 | Save ~$933/mo |
Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long–term solution:
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact Afford My Prescriptions directly so we can review your specific situation.
Duobrii (halobetasol propionate 0.01% / tazarotene 0.045% lotion) is a prescription combination topical treatment for plaque psoriasis in adults. It is the first and only fixed-dose combination of a corticosteroid (halobetasol) and a retinoid (tazarotene) in a single lotion, designed to simultaneously reduce inflammation and normalize the excessive skin cell growth that produces psoriasis plaques. You apply a thin layer once daily to affected areas, including the scalp if directed by your doctor. The maximum dose is 50 grams per week.
How It Works:
Plaque psoriasis is driven by two interconnected problems in your skin. First, your immune system is overactive — it sends inflammatory signals to the skin that cause redness, swelling, itching, and pain. Second, this inflammation triggers skin cells to reproduce at a wildly accelerated rate: instead of the normal 28-day cycle of growth and shedding, new skin cells are produced every 3 to 4 days. These excess cells pile up on the surface, forming the thick, silvery white plaques that define the condition.
Duobrii attacks both problems simultaneously with two complementary active ingredients. Halobetasol propionate is a potent corticosteroid that suppresses the overactive immune signals driving inflammation in your skin. It reduces the redness, swelling, itching, and pain of active plaques by dampening the immune cells and inflammatory chemicals at the site. Tazarotene is a retinoid (a form of vitamin A) that normalizes the rate at which your skin cells grow and shed.
It slows the rapid cell turnover that produces the thick plaques and promotes the growth of healthier, more normal skin. What makes Duobrii unique is that these two ingredients are formulated together at specific low concentrations (0.01% halobetasol and 0.045% tazarotene)\ designed to maximize effectiveness while minimizing the irritation that can occur with either
ingredient alone.
Form and Use:
Available as a 100-gram tube of lotion. Apply a thin layer once daily to affected areas of skin and wash your hands afterward. The maximum dose is 50 grams per week. Avoid application to the face, groin, and underarms unless specifically directed by your dermatologist.
Generic Availability:
As of April 2026, there is no generic version of Duobrii (halobetasol propionate 0.01% / tazarotene 0.045% lotion) available in the United States. The specific fixed-dose combination of halobetasol and tazarotene at these concentrations has no direct generic equivalent. While generic halobetasol cream and generic tazarotene cream are each available individually, they are not formulated to work together in the same way as Duobrii’s engineered combination. Until a generic becomes available, the Patient Assistance Program through AffordMyPrescriptions provides Duobrii at no medication cost for $69.95 per month — the most affordable pathway for
patients who need this first-in-class combination psoriasis treatment.
Warnings:
Duobrii must not be used during pregnancy — the tazarotene component can cause birth defects. Women of childbearing potential must have a pregnancy test before starting treatment and use effective birth control throughout treatment. Do not use on skin with eczema, sunburn,
or open wounds. Excessive use may be absorbed through the skin and affect adrenal gland function — your doctor will monitor for this. Stop use and contact your dermatologist if you experience severe skin irritation or signs of skin thinning.
Duobrii costs approximately $1,001–$1,241 per 100-gram tube at retail. The manufacturer offers copay savings at participating pharmacies for commercially insured patients (as little as $25 per fill for some eligible patients). Through AffordMyPrescriptions, qualifying patients receive Duobrii at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Yes. The Duobrii provided through the Patient Assistance Program is the identical FDA approved brand-name medication dispensed at U.S. pharmacies. It ships in the
manufacturer’s original packaging directly to you or to your prescribing dermatologist.
No. As of April 2026, there is no generic version of Duobrii’s specific halobetasol/tazarotene lotion combination available in the U.S. While generic halobetasol and generic tazarotene are available individually, they are not formulated to work together in the same way. Until a generic becomes available, the PAP is the most affordable pathway for Duobrii access.
Duobrii combines both ingredients in a single application at specifically calibrated low concentrations (0.01% halobetasol and 0.045% tazarotene) designed to work
synergistically while reducing irritation. Using separate products requires two applications and may cause more irritation at their standard concentrations. However, using generic halobetasol plus generic tazarotene separately costs $70–$140 total — ask your dermatologist if this alternative would work for you.
No. Duobrii must not be used during pregnancy because the tazarotene component can cause birth defects. Women of childbearing potential must have a pregnancy test before starting treatment and use effective birth control throughout treatment. If you become pregnant while using Duobrii, stop immediately and contact your healthcare provider.
Our Patient Advocates will immediately explore every alternative — including the manufacturer’s copay savings card (for commercially insured patients), generic
halobetasol cream plus generic tazarotene cream used separately ($70–$140 combined), apremilast (oral psoriasis treatment) already available through our service, other topical psoriasis treatments including generic calcipotriene/betamethasone combination, insurance formulary exception requests with documentation of treatment history, and biologic psoriasis medications with their own PAPs for moderate-to-severe disease. If we can’t help, you won’t be charged.
If you are struggling with the high cost of Duobrii, our team may be able to help you
access assistance programs designed to make medications more affordable. Check
your eligibility today and take the first step toward reducing your prescription costs.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.